Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.

Heelan, Bridget T

Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. [electronic resource] - British journal of haematology Sep 2002 - 1078-81 p. digital

Publication Type: Case Reports; Journal Article

0007-1048

10.1046/j.1365-2141.2002.03753.x doi


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antigens, CD19--blood
Antineoplastic Agents--therapeutic use
Antineoplastic Agents, Phytogenic--therapeutic use
Autoimmune Diseases--drug therapy
Child
Combined Modality Therapy
Humans
Immunoglobulin G--blood
Lymphoproliferative Disorders--drug therapy
Male
Mutation
Platelet Count
Proteins--genetics
Rituximab
TNF Receptor-Associated Factor 6
Thrombocytopenia--drug therapy
Vincristine--therapeutic use